Tivozanib 11014-0457
Product NDC
11014-0457- Manufacturer
- Catalent Pharma Solution, Llc
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- Marketing Start
- March 10, 2021
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tivozanib Hydrochloride | .89 mg/1 |
Packaging Options(1)
1 BAG in 1 DRUM (11014-0457-2) / 93750 CAPSULE in 1 BAG